Janssen-Cilag's Xeplion recommended for EU approval for schizophrenia
This article was originally published in Scrip
Executive Summary
Janssen-Cilag's (Johnson & Johnson) injectable drug Xeplion (paliperidone palmitate) has been recommended for European approval by the CHMP for the treatment of schizophrenia.